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become CD4 or CD8 single positive (SP) cells that emi-Ursula von Freeden-Jeffry,²
grate to the periphery and participate in immune re-Richard Murray,² and Irving L. Weissman*
sponses (Adkins et al., 1987; Weissman, 1994). In the*Departments of Pathology and
thymus, gc is expressed in virtually all thymocytesDevelopmental Biology
(Kondo et al., 1994b), while IL-7Ra has been reportedStanford University School of Medicine
to be expressed in DN TCR2 thymic precursors andStanford, California 94305
mature TCRhi SP cells, but not in the majority of TCRlo²Department of Immunology
DP cells (Sudo et al., 1993) that contain precursors withDNAX Research Institute of Cellular and
selectable TCR. The major role of the IL-7/IL-7Ra inter-Molecular Biology
action has been considered to be the expansion of DNPalo Alto, California 94304
thymic precursors; IL-7- or IL-7Ra-deficient (IL-7Ra2/2)
mice showed a decreasein the number of thymic precur-
sors (Peschon et al., 1994; von Freeden-Jeffry et al.,Summary
1995). IL-7 may have an important role during positive
selection, because thymocytes undergoing positive se-
Mice lacking functional IL-7 or IL-7Ra genes are
lection express IL-7Ra and/or c-Kit throughout the DP-
severely deficient in developing thymocytes, T cells, to-SP transition (Akashi and Weissman, 1996; Akashi et
and B cells. IL-7 and IL-7 receptor functions are be- al., submitted). In addition, the rare peripheral T cells in
lieved to result in lymphoid cell proliferation and cell the IL-7Ra2/2 mice showed impaired survival and less
maturation, implying signal transduction pathways di- responsiveness to both TCR-dependent and -indepen-
rectly involved in mitogenesis and elaboration of de- dent stimuli, though IL-7/IL-7R signaling is not essential
velopmentally specific new gene programs. Here, we for T cell activation (Maraskovsky, et al., 1996). These
show that enforced expression of the bcl-2 gene in data suggest an intrinsic abnormality of IL-7Ra2/2 T cells
T-lymphoid cells (by crossing in the Em-bcl-2 trans- that is possibly due to a lack of IL-7R-mediated signals
gene) in IL-7Ra-deficient mice results in a significant during positive selection.
restoration of thymic positiveselection and T cell num- Bcl-2 is an antiapoptosis protein (Vaux et al., 1988,
bers and function. We propose cell survival signals to 1992; Hockenbery et al., 1991; Sentman, et al., 1991;
be the principal function of IL-7R engagement in thy- Strasser et al., 1991; Cory, 1995). Bcl-2 can protect de-
mic and T cell development. veloping and mature T cells against a variety of apop-
totic signals such as glucocorticoids and cross-linking
of cell surface molecules by anti-CD3 antibody. Bcl-2Introduction
is expressed at all stages of cells undergoing positive
selection, including DN and SP cells, but not in the ma-Interleukin-7 (IL-7) is a nonredundant cytokine for both
jority of the DP cells that have failed positive selectionT cell and B cell development (Peschon et al., 1994; von
and that will die by default (Gratiot-Deans et al., 1993,Freeden-Jeffry et al., 1995). IL-7 exerts its effect through
1994; Veis et al., 1993a; Akashi and Weissman, 1996).the interaction of a high affinity receptor complex com-
Bcl-2-deficient mice showed a gradual disappearanceposed of the IL-7Ra and the common cytokine receptor
of T (and B) cells after the second postnatal week of lifeg chain (gc) (Noguchi et al., 1993a; Kondo et al., 1994a),
(Veis et al., 1993b; Nakayama et al., 1994). This suggestswhich is also an indispensable subunit for functional
that Bcl-2 may protect thymocytes undergoing positiveIL-2 (Takeshita et al., 1992), IL-4 (Kondo et al., 1993;
selection (Linette et al., 1994; Tao et al., 1994; AkashiRussell et al., 1993), IL-9 (Kimura et al., 1995), and IL-
and Weissman, 1996) as well as peripheral T cells from
15 (Giri et al., 1994) receptors. Injection with neutralizing
apoptotic stimuli such as levels of endogenous gluco-
antibodies to IL-7 or genetic ablation of either IL-7, IL-
corticoid reached in the diurnal cycle (Weissman, 1994)
7Ra, or gc inhibits both T and B cell development or stress.
(Peschon et al., 1994; Bhatia et al., 1995; Cao et al., The enforced expression of Bcl-2 has been shown
1995; DiSanto et al., 1995; von Freeden-Jeffry et al., to maintain the viability of various cytokine-dependent
1995; Ohbo et al., 1996). The molecular pathogenesis cells upon withdrawal of their dependent cytokines in
of X-linked severe combined immunodeficiency (SCID) vitro (for reviews, see Vaux, 1993 and Yang and Kors-
in humans might be due primarily to gc-mediated defects meyer, 1996). In these situations, Bcl-2 itself does not
in the IL-7/IL-7R system (Stephan et al., 1997) caused stimulate proliferation, but appears to enable cells to
by mutation of the gc gene (Noguchi et al., 1993b; Puck undergo intrinsically-determined differentiation through
et al., 1993). maintenance of the viability of the cells in vitro (Fairbairn
Thymic maturation from CD42CD82 (DN) primitive et al., 1993). Based on these data, we hypothesized
progenitors involves rearrangement of TCR genes; ex- that an important role of IL-7/IL-7R interactions in T cell
pression of TCR with CD4 and CD8 coreceptors; positive development was to maintain cell survival. To test this
selection of CD41CD81 double positive (DP) cells that hypothesis, we introduced an Em-bcl-2 transgene that
corecognize self MHC class II molecules with CD4 and is selectively expressed in T lineage cells into IL-7Ra2/2
TCR, and self MHC class I with CD8 and TCR; negative mice. We show here that enforced expression of Bcl-2
in IL-7Ra2/2 mice results in a rescue of T lymphopoiesis.selection of autoimmune T cells; and commitment to
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selection had increased the expression of both mole-
cules. Expressionof both IL-7Ra and Bcl-2 is maintained
in differentiated thymic TCRhi SP cells (Figure 1A) as well
as spleen TCRhi T cells. However, in IL-7Ra2/2 mice, the
upregulation and maintenance of Bcl-2 is apparently
impaired (Figure 1B); the levels of endogenous Bcl-2 in
thymocyte subsets such as DN, CD4 SP and CD8 SP
cells, and those in spleen T cells in IL-7Ra2/2 mice were
significantly lower than those in IL-7Ra1/2 mice. These
data suggest a possible link between IL-7/IL-7R interac-
tion and endogenous Bcl-2 expression in T cells. To test
this, we evaluated the effect of IL-7R engagement on
endogenous Bcl-2 expression in T cells taken from IL-
7-deficient (IL-72/2) mice. As shown in Figure 1C, T cells
isolated from the spleens of IL-72/2 mice showed a re-
duction of Bcl-2 levels. However, when IL-72/2 T cells
were cultured with recombinant IL-7 for 18 hr, Bcl-2
levels were significantly increased. These data strongly
suggest that IL-7R signaling might involve maintenance
of Bcl-2 expression in developing thymocytes as well
as in peripheral T cells.
IL-7R Signaling Is Required for Positive Selection
To clarify the possible role of IL-7R signaling in positive
Figure 1. IL-7R Engagement Induces Expression of Bcl-2 during T selection, we evaluated the effect of neutralizing anti-
Cell Maturation
IL-7Ra antibody (A7R34) (Sudo et al., 1993) on the in
(A) The expression of IL-7Ra and endogenous Bcl-2 in thymocytes.
vivo maturation of thymocytes. For these experiments,DP cells are negative for both IL-7Ra and Bcl-2, whereas SP are
we used a model wherein thymic lymphocytes from MHCpositive for both. The TCRmed CD691 cells (closed gray histogram)
class I± and II±deficient (MHC2/2) mice were injectedthat are in the process of positive selection have upregulated both
IL-7Ra and endogenous Bcl-2. into the thymi of MHC1/1 mice (Akashi et al., submitted),
(B) The expression of endogenous Bcl-2 in DN thymocytes (i), CD4 and were followed for their maturation in the presence
SP (ii) and CD8 SP thymocytes (iii), and splenic T cells (iv), in either or absence of A7R34. Since thymocytes from MHC2/2
IL-7Ra2/2 (7R2/2; closed gray histogram) or IL-7Ra1/2 (7R1/2) mice mice could not have received signals for positive selec-
(C) The upregulation of Bcl-2 in splenic TCRb1 T cells from IL-72/2
tion, the MHC2/2 thymocytes should contain precursorsmice after culturing for 18 hr with IL-7.
that express selectable TCRs in high frequencies. InData from each group of three mice are plotted. (*), p , 0.05by paired
t tests compared on each mean value of fluorescence intensity. this experimental system, there was an increase in the
numbers of SP progeny 3 days and 7 days after intra-
thymic injection; the SP (mainly CD4 SP) cells that ap-
peared after 3 days were mainly the progeny of DPResults
(c-Kit2) precursors; and the SP cells (both CD4 and CD8
SP cells) that appeared after 6±7 days were progeny ofIL-7R Engagement Induces High Level Expression
of Bcl-2 during T Cell Maturation more immature DN to DPlo c-Kit1 IL-7Ra1 precursors
(Akashi et al., submitted). As shown in Figure 2A, theThe first step of thymic positive selection includes an
upregulation of their TCRs to medium±high levels (Gui- administration of A7R34 suppressed the differentiation
of MHC2/2 thymocytes along both the c-Kit1 and thedos et al., 1990; for reviews, see von Boehmer, 1994;
Jameson et al., 1995; Guidos 1996). This process begins c-Kit2 pathways (Akashi and Weissman, 1996) to both
CD4 and CD8 SP cells on days 3 and 7.at the DP stage (Shortman et al., 1991; Akashi and
Weissman, 1996). CD69 is an activation marker that is It was important to determine the role of cell division
during positive selection in these experiments, becauseexpressed on cells undergoing positive selection (Swat
et al., 1993; Yamashita et al., 1993; Brandle et al., 1994). the decrease of day 3 or day 7 progeny could result
simply from the suppression of IL-7-dependent prolifer-The positively selected cells downregulate either irrele-
vant CD4 or CD8 coreceptor (Guidos et al., 1990; Lucas ation by A7R34. Indeed, the decrease of day 7 progeny
by A7R34 might result from the inhibition of IL-7-depen-and Germain, 1996; von Boehmer, 1996), and complete
TCR upregulation. All cells undergoing positive selection dent expansion of the c-Kit1 IL-7R1 precursors (the
c-Kit1 pathway; Akashi and Weissman, 1996), since weexpress the IL-7R (Akashi et al., submitted).
Figure 1A shows IL-7Ra and Bcl-2 expression in thy- have found that injection of A7R34 could inhibit the
proliferation of c-Kit1 IL-7R1 precursors in normal micemocytes in IL-7Ra1/2 mice. Because virtually all thymo-
cytes express gc (Kondo et al., 1994b), thymocytes that (Akashi et al., submitted). To understand the role of cell
division of thymocytes during positive selection for dayexpress the IL-7Ra chain should possess a functional
IL-7R heterodimer on their surface. While the majority 3 CD4 SP progeny, we isolated DP c-Kit2 thymocytes
from MHC2/2 mice, labeled the cells with PKH26, in-of DP (TCRlo CD692) cells did not express IL-7Ra or
Bcl-2, the TCRmed CD691 population undergoing positive jected the labeled cells intrathymically into normal hosts,
Survival Signals from IL-7 Receptor
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Figure 2. Inhibition of Positive Selection by a Neutralizing Anti-IL-
7Ra Antibody (A7R34)
(A) Numbers of CD4 or CD8 SP progeny from unfractionated MHC2/2
(Ly5.2) thymocytes, 3 or 7 days after intrathymic injection into
MHC1/1 (C57BL/6-Ly5.1) thymi with or without intraperitoneal injec-
tion of A7R34.
(B) Numbers of CD4 SP progeny 3 days after intrathymic injection
of purified DP (2 3 106) cells from either MHC2/2 or Em-bcl-2 MHC2/2
thymus in the presence or absence of A7R34.
(*), P , 0.05 by paired t tests.
and assessed the change in PKH26 intensity. A decline
in the fluorescence signal from PKH26-labeled thymic
population should be correlated with the number of cell
divisions; each doubling of labeled cells corresponds
to a 50% drop of the mean fluorescent signal as the dye
present in the plasma membrane of the parent cell was
divided between two daughter cells (Kraft et al., 1993). Figure 3. Substitution for IL-7R-Mediated Signals during Positive
As shown in Figure 3A, the mean PKH26 intensity of Selection by Enforced Expression of Bcl-2
day 3 CD4 SP progeny corresponds to cells that had (A) Cell cycle status during positive selection determined by cell
undergone only ,0.1 cell cycles, indicating that the tran- membrane staining of PKH26. (i), CD4/CD8 profile of day 3 progeny
from purified DP (2 3 106) cells stained with PKH26. (ii), the PKH26sition from MHC2/2 DP c-Kit2 to CD4 SP progeny by
fluorescence of day 3 CD4 SP progeny after intrathymic injectionpositive selection on day 3 post injection occurred
of DP cells from MHC2/2 thymus to congenic MHC1/1 thymusmostly without cell division. Accordingly, the effect of
(closed gray line). The mean PKH26 intensity of day 3 CD4 SP
A7R34 could be ascribed not only to suppression of progeny is virtually the same as the control value depicted as an
thymocyte proliferation, but also to inhibition of positive inverted closed triangle (see Experimental Procedures), indicating
selection through inhibiting cell survival, differentiation, that cell division is not involved in the transition from DP to CD4 SP
cells. (iii), the rapid decrease of PKH26 intensity of cells maintainingor both.
the TCR2 c-Kit1 phenotype 3 days after intrathymic injection of
cycling TCR2 c-Kit1 cells (closed gray line). Broken lines correspondIL-7R Signaling during Positive Selection Could
to the 50% decrease of fluorescence intensity of PKH26. The num-
Be Substituted by Enforced Expression bers at the top of bottom panels depict the estimated numbers of
of the bcl-2 Transgene cell divisions as determined by the decline of PKH26 intensity.
To test whether a survival signal is involved, we provided (B) The CD4/CD8 profiles of progeny 3 days after intrathymic injec-
tion of purified DP (2 3 106) cells from either MHC2/2 or Em-bcl-2a survival signal (expression of the human bcl-2 trans-
MHC2/2 thymus. Absolute numbers of progeny are shown in Figuregene) for cells undergoing thymic positive selection
2B. A7R34 could inhibited the positive selection from DP to CD4by using Em-bcl-2 MHC2/2 mice as donors. We injected
SP cells, but Em-bcl-2 could antagonize this inhibitory effect of
purified DP c-Kit2 cells from either MHC2/2 or Em-bcl-2 A7R34 on positive selection.
MHC2/2 mice into MHC1/1 thymi in the presence or ab-
sence of A7R34. After intrathymic injection, the posi-
tively selected DP cells immediately upregulated IL-7Ra
cells to complete the developmental program specifiedand TCRb (data not shown). This process does not in-
by positive selection, probably by maintaining their via-volve cell division (as described above). As shown in
bility.Figures 2B and 3B, DP c-Kit2 cells lacking Bcl-2 were
blocked in their differentiation to SP (CD4) cells by
A7R34, whereas the inhibitory effect of A7R34 was not Enforced Expression of Bcl-2 Restores T
Cell Development in IL-7Ra2/2 Micefound on Em-bcl-2 MHC2/2 DP cells. Based on these
data, we propose that the IL-7/IL-7R interaction is un- If IL-7 induces a survival response during thymic positive
selection, Bcl-2 expression should rescue thymic cellslikely to play a direct role in determining the differentia-
tion of DP progenitors, but is important in permitting DP that had been largely absent in IL-7Ra2/2 mice (Peschon
Cell
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Figure 5. Enforced Expression of Bcl-2 Restores Distribution of
Thymocytes Undergoing Positive Selection in IL-7Ra2/2 Mice
(A) CD4/CD8, CD69/TCRb, and c-Kit/TCRb expression profiles of
thymocytes.
(B) Human Bcl-2 expression driven by Em-bcl-2 transgene (closed
gray histogram) in c-Kit1 populations that express different levels
Figure 4. Enforced Expression of Bcl-2 Leads to a Recovery of T of TCRb from the Em-bcl-2 IL-7Ra2/2 thymus ([a]±[d]; defined in the
Cell Population in IL-7Ra2/2 Mice middle of bottom panels of [A]). Open histograms show control
stainings with FITC-conjugated goat anti-hamster IgG in each sub-(A) B220/TCRb (upper panels) and CD4/CD8 (lower panels) expres-
set. Human Bcl-2 was expressed in the TCR1 c-Kit1 populationssion profiles of cells from peripheral blood.
(b±d), but not in the TCR2 c-Kit1 early precursors (a).(B) Absolute numbers of a/b T (TCRb1) cells and B (B2201) cells
per microliter of peripheral blood, and splenic T (TCRb1) cells in
either IL-7Ra2/2 (closed circle), Em-bcl-2 IL-7Ra2/2 (open circle), or
as well as in the number of mature TCRhi SP subsetsIL-7Ra1/2 (open triangle) mice. Mean values are indicated by the
bars and adjacent numbers. (*), p , 0.05 by the Bonferroni method (Figures5 and 6). The CD4 versus CD8 expression profile
on positive results of the Kruskal-Wallis test. of thymic lymphocytes is restored in Em-bcl-2 IL-7Ra2/2
mice to the profiles of normal thymus (Figure 5A). In the
small number of cells in the IL-7Ra2/2 thymus, the ratioet al., 1994). To test this possibility, we introduced Em-
bcl-2 mice into the IL-7Ra2/2 strain by breeding and of CD4/CD8 SP thymocytes was widely variable. Expres-
sion of Bcl-2 in these thymi led to an almost normalizedselection of Em-bcl-2 IL-7Ra2/2 progeny. Results from
the analysis of Em-bcl-2 IL-7Ra2/2 mice are shown in CD4/CD8 SP ratio, confirming that Em-bcl-2 could res-
cue both CD4 and CD8 lineage maturation (Figures 5AFigures 4, 5, and 6. Em-bcl-2 IL-7Ra2/2 mice produced
a significant amount of peripheral T cells, approximately and 6). The small number of cells in the IL-7Ra2/2 thymus
are also disproportionately skewed to TCRhi SP cells;10-fold greater than those severely depleted in IL-
7Ra2/2 mice (Figure 4); the number of T cells from Em- the ratio of CD691 to CD692 cells in TCRmed±hi population
in the IL-7Ra2/2 thymus was low, indicating that thebcl-2 IL-7Ra2/2 mice increased z7-fold in blood and
z11-fold in spleen. The ratio of CD4 to CD8 SP cells in majority of these cells had not recently been positively
selected (Figure 5A). On the other hand, the percentagethese mice was almost equal to that in IL-7a1/2 mice
(Figure 4A). We found no particular Vb bias in the restora- of TCRmed±hi CD691 thymocytes in Em-bcl-2 IL-7Ra2/2
mice is similar to that in IL-7Ra1/2 mice. The absolutetion of peripheral CD4 or CD8 cells in Em-bcl-2 IL-7Ra2/2
mice; either CD4 or CD8 SP cells contained similar per- numbers of CD691 cells in Em-bcl-2 IL-7Ra2/2 thymus
showed an z10-fold increase compared to those incentages of Vb3-, Vb6-, Vb8-, and Vb11-positive cells
when compared to normal mice (data not shown). How- IL-7Ra2/2 thymus (Figure 6).
TCRlo±hi c-Kit1 cells represent an efficient progenitorever, B cells were not rescued (Figure 4B), and g/d T
cells remained undetectable in lymph nodes (data not population for receiving positive selection (Akashi and
Weissman, 1996). While c-Kit1 cells were absent fromshown).
In the Em-bcl-2 IL-7Ra2/2 thymus, there was a signifi- the IL-7Ra2/2 thymus, these populations were also re-
stored in the Em-bcl-2 IL-7Ra2/2 thymus both in numbercant increase in the number of thymocytes (z10-fold)
Survival Signals from IL-7 Receptor
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Figure 7. Enforced Expression of Bcl-2 Restores Function of IL-
7Ra2/2 T Cells
Results of activation assays of splenic T cells against nonspecific
TCR stimulation by either ConA (A) or anti-CD3 plus anti-CD28 (B),
and allogeneic stimulation evaluated by mixed lymphocyte cultures
(C). Data was shown as mean 6 S.D. (error bars) in quadriplicate
cultures. (*), P , 0.05 by paired t tests.
maintain viability, at least including upregulation ofFigure 6. Enforced Expression of Bcl-2 Restores Numbers of Devel-
Bcl-2. The survival signal induced by IL-7 could involveoping Thymocytes in IL-7Ra2/2 Mice
molecules other than Bcl-2, because IL-7 can reinforceAbsolute numbers of each phenotypically defined thymic population
the survival of T cells from Bcl-2-deficient mice (Naka-and CD4/CD8 ratio of TCRbhi SP thymocytes in either IL-7Ra2/2
(closed circle), Em-bcl-2 IL-7Ra2/2 (open circle), or IL-7Ra1/2 (open yama et al., 1995).
triangle) mice. Mean values are indicated by the bars and adjacent Previous studies showed that Bcl-2 itself had no stim-
numbers. (*), p , 0.05 by Bonferroni method on positive results of ulatory effect on cell proliferation (Vaux et al., 1988;
the Kruskal-Wallis test.
Fairbairn et al., 1993; Mazel et al., 1996), although it is
conceivable that Bcl-2 could be involved in preparing
cells for mitosis. Bcl-2 could not substitute for signals
and in the various stages of the c-Kit1 maturation path-
generated during positive selection driven by TCR±MHC
way (Akashi and Weissman, 1996) (Figure 6). These data
interactions, because no SP maturation could be seen
show significant restoration of thymocyte numbers and
in lckpr±bcl-2 MHC2/2 mice (Linette et al., 1994; Tao et
regeneration of all maturational stages of positive se-
al., 1994) or in the Em-bcl-2 MHC2/2 mice used in this
lection.
study (data not shown). T cells were also not rescued
in lckpr±bcl-2 RAG12/2 (Linette et al., 1994) or Em-bcl-2The Restored T Cells in Em-bcl-2 IL-7Ra2/2
SCID mice (Strasser et al., 1994). Enforced expressionMice Are Functional
of Bcl-2 was reported to increase the number of CD3med±hiIt was important to test whether the phenotypic restora-
CD8 SP cells in the thymus (Linette et al., 1994; Tao ettion of T cells in the Em-bcl-2 IL-7Ra2/2 mice signified
al., 1994), although its effect on positive selection wasfunctional maturation. Although IL-7R signaling was not
not clear.required for T cell activation, IL-7Ra2/2 T cells have been
In our study, the Em-bcl-2 transgene could restoreshown to be less responsive to alloantigen as well as to
thymic development in IL-7Ra2/2 mice. Developing thy-receptor-independent stimuli (Maraskovsky et al., 1996).
mocytes in IL-7Ra2/2 mice expressed low levels of en-As shown in Figure 7, IL-7Ra2/2 T cells were significantly
dogenous Bcl-2. Em-bcl-2 could substitute for the IL-less responsive to either concanavalin A (ConA), anti-
7R-mediated signals associated with positive selectionCD3 plus CD28 stimulations, or allogeneic antigen as
in a subset of progenitors (DPhi c-Kit2) that did not un-evaluated on a mixed lymphocyte reaction. In all of these
dergo cell division in vivo during their maturation to CD4assays, Em-bcl-2 IL-7Ra2/2 T cells on a per cell basis
(TCRhi) SP cells. These results indicate that enforcedcould respond significantly better than the residual T
expression of Em-bcl-2 did not necessarily lead to posi-cells in IL-7Ra2/2 mice, and almost as well as T cells
tive selection by modifying the cell cycle status of cellsfrom IL-7R1/2 mice.
on the c-Kit2 pathway (Linette et al., 1996; Mazel et al.,
1996). Accordingly, the reinforcement of survival by Em-Discussion
bcl-2 enables thymocytes to complete the differentia-
tion program determined by positive selection and leadsOur data show that enforced expression of Bcl-2 in T
to significant increases in both CD691 and TCRlo±hi c-Kit1lineage cells could restore T cell development consider-
thymocyte populations.ably in IL-7Ra2/2 mice. Accordingly, it is strongly sug-
The survival signal induced by IL-7R might also playgested that the principal role of IL-7R signaling in devel-
oping thymocytes and mature T cells might be to a role in the proliferation of thymic precursors. We have
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reported that in normal mice, Bcl-2 expression is main- spleen (Young et al., 1997). Accordingly, it appears that
the particular signal transduction events responsible fortained through all stages of the positive selection pro-
cess including cycling TCRlo±med c-Kit1 IL-7Ra1 (DN to the rearrangement of g/d TCR and IgH genes cannot be
rescued by the survival-promoting bcl-2 transgene.CD4intCD8int) cells, TCRhi c-Kit1 IL-7Ra1 CD4loCD81 or
CD41CD8lo cells, and TCRhi c-Kit2 SP cells (Akashi and It is still unclear whether positively selected thymo-
cytes undergo apoptoticcell death invivo in the absenceWeissman, 1996). The c-Kit ligand, steel factor (Slf) is
also a factor responsible for expansion of immature thy- of IL-7R-mediated signals, though in vitro survival of IL-
7R2/2 mature T cells is impaired (Maraskovsky et al.,mocytes (Rodewalt et al., 1995), and the proliferation of
c-Kit1 IL-7Ra1 thymocytes is synergistically supported 1996). Hence, there remains a possibility that Bcl-2 may
play a role in activating intracellular maturation pro-by IL-7 and Slf (Suda and Zlotnik, 1991; Akashi et al.,
submitted). Accordingly, Em-bcl-2 may maintain the re- grams (Chen et al., 1997) as well as in maintaining cell
survival during positive selection. Further studies ofsponsiveness to Slf in TCRlo±med c-Kit1 populations in the
IL-7R2/2 thymus. However, the restoration of thymocyte downstream events associated with the expression of
Bcl-2 are required to clarify this issue.numbers by Em-bcl-2 was not complete. This may be
at least partially because the Em-bcl-2 transgene was The possibility that other cytokines might have as a
significant function the induced survival of their targets,not expressed before thedevelopmental stages of TCR2
c-Kit1 precursors (Figure 5B) that has not rearranged rather than directing differentiation in vivo, may be more
general than the IL-7/IL-7R model described here. Else-TCR genes.
The malfunction of peripheral IL-7Ra2/2 T cells upon where, we present evidence that M-CSF delivers a sur-
vival signal for target monocytes in vivo, and that en-stimulation has been characterized as reduced fre-
quency of clonogenic expansion due to an increased forced expression of Bcl-2 in monocytes in op/op mice
can rescue the differentiation of macrophage subsetsrate of apoptotic cell death and a slower rate of prolifera-
tion (Maraskovsky et al., 1996). The lack of IL-7R signal- and significant reversal of their osteopetrosis (Lagasse
and Weissman, 1997 [this issue of Cell]). Thus, certaining results in impaired expression of endogenous Bcl-2
in IL-7Ra2/2 T cells, and might cause their augmented cytokines appear to enforce viability of their target cells
in vivo. In the case of IL-7/IL-7R, proliferation and/orrate of apoptosis. The Em-bcl-2 transgene protects IL-
7Ra2/2 T cells from apoptosis probably before and after maturation of T cells that result from internal gene pro-
grams or other external stimuli (including other cytokineactivation, and normalizes their in vitro response to ei-
ther antigen-specific or antigen-independent stimuli. receptor/cognate cytokine interactions) could occur on
condition that the cells do not die.The hypoplasia of the lymphoid system in IL-7Ra2/2
mice is probably not simply due to the disruption of
IL-7/IL-7R interaction, because IL-7Ra is also used as
Experimental Procedures
a receptor for other ligands, e.g., for receptor complexes
of thymic stromal cell±derived lymphopoietin (Friend et Mice
C57BL/6-Ly5.1 mice were bred and maintained in the central animalal., 1994; Ray et al., 1996). We found a similar impairment
facility in the Department of Comparative Medicine, Stanford Univer-of endogenous Bcl-2 expression in developing thymo-
sity. The MHC2/2 mice were obtained by crossing mice with H-2bcytes in gc-deficient (gc2/2) mice (K. A. et al., unpublished haplotype (Ea2) (Ly5.2) introduced with a targeted mutation in the
data), whose lymphopenia is mostly due to a lack of
b2-microglobulin gene (MHC class I±deficient mice) and mice with
functional IL-7R (Sadlack et al., 1994). We have observed a null mutation in the Abb gene (MHC class II-deficient mice). Em-
T cell but not B cell restoration by introducing either the bcl-2-25 mice, in which the human bcl-2 transgene is expressed
mainly in T-lineage cells (Strasser et al., 1991), were backcrossedEm-bcl-2 or the H2K-bcl-2 transgene into the gc2/2 mice,
with C57BL/Ka (H-2b) (Ly5.2) for three generations. The MHC2/2 Em-in the latter of which the bcl-2 transgene was expressed
bcl-2 mice were generated by crossing with the Em-bcl-2-25 micein virtually all hematopoietic cells (Kondo et al., 1997).
and the MHC2/2 mice. IL-7Ra2/2 mice were obtained from the Jack-Therefore, the primary immunopathological mechanism
son Laboratories (Bar Harbor, Maine). Em-bcl-2 IL-7Ra2/2 mice were
of impaired development of T cells in X-linked SCID generated by crossing the IL-7Ra2/2 mice with the Em-bcl-2-25
might be due to lack of survival signals induced by IL- mice. All mice were analyzed at 4±5 weeks of age.
7R engagement in the thymus.
It is also suggested that the rescue of lymphopoiesis Antibodies
by the bcl-2 transgene in IL-7Ra2/2 mice might be re- The antibodies used in immunofluorescence staining included AL1-
stricted to a/b T cells; the Em-bcl-2 transgene appears 4A2 (anti-Ly5.2); 2B8 (anti-c-Kit, CD117) (Ikuta and Weissman, 1992);
KT-31 or 2C11 (anti-CD3); H57-579 (anti-TCRb); GK-1.5 (anti-CD4);not to be able to rescue g/d T and B cells, although the
53-6.7 (anti-CD8) and 6B2 (anti-B220) and F23.1 (anti-Vb8.2). Neu-Em-bcl-2 was expressed in a considerable fraction of
tralizing anti-IL-7R (A7R34) antibodies are kind gifts from S. Nishi-the IgM2 B2201CD431 pro-B cell population in bone
kawa (Kyoto University). Mouse and hamster antibodies were puri-
marrow (data not shown). Engagementof the IL-7R com- fied by protein A affinity chromatography, and rat antibodies were
plex is reported to be critical for the development of g/d purified by protein G affinity chromatography. These antibodies are
T cells (Appasamy et al., 1993; He and Malek, 1996; directly conjugated with phycoerythrin (PE) (Cyanotech Corporation,
Kailua-Kona, Hawaii), fluorescein-5isothiocyanate (FITC) (MolecularMaki et al., 1996). The IL-7R complex also plays a crucial
Probes, Incorporated, Eugene, Oregon), allophycocyanin (APC) (Cy-role in the rearrangement of immunoglobulin heavy
anotech Corporation), or Texas Red (Molecular Probes). A7R34 waschain (IgH) genes (Corcoran et al., 1996). When a re-
biotinylated and visualized by avidin-PE (Becton Dickinson and Co.,
arranged IgH gene is introduced into RAG2/2 mice, the San Jose, California). FITC-conjugated H1.2F3 (anti-CD69), KJ 25
Em-bcl-2 gene promotes the maturation of pro-B to (anti-Vb3), RR-47 (anti-Vb6), andRR3-15 (anti-Vb11) werepurchased
pre-B cells, resulting in the formation of classical splenic from PharMingen (San Diego, California). The staining of Bcl-2 was
done as follows; after staining for surface antigens, the cells wereB cell follicles (Gutman and Weissman, 1972) in the
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stained with purified hamster anti-mouse Bcl-2 antibody (Phar- Proliferation Assay
Splenocytes were isolated and depleted of erythrocytes with ACKmingen) for 1 hr, then incubated with FITC-conjugated goat anti-
hamster IgG (Caltag Laboratories, San Francisco, CA) for 30 min in treatment. Splenic T cells were enriched through negative selection
of splenocytes by using Gr-1 (8C5), Mac-1 (M1/70) plus B220 (6B2)PBS containing 0.03% saponin and 5% FCS.
rat antibodies, and sheep anti-Rat antibody-conjugated immuno-
magnetic beads (Dynabeads M-450, Dynal A.S., Oslo, Norway). InCulture of Splenic T Cells
most cases, T cells were enriched up to z80%. Enriched splenic TEnriched splenic T cells (2 3 106/ml) from either IL-7Ra1/2 or IL-
cells (containing 5 3 104 T cells) were incubated for 2 days at 378C,72/2 mice were cultured in RPMI-1640 containing 10% FCS with or
7% CO2 in 96-well plates in RPMI-1640 with 10% FCS, and supple-without 20 ng/ml of recombinant mouse IL-7 (Genzyme, Cambridge,
ments in the presence or absence of plate-bound anti-CD3MA) at 378C in 7% CO2 and 100% humidity for 18 hr. No proliferation
(145.2C11) and CD28 (Pharmingen) (plates were coated with theseof either IL-72/2 or IL-7Ra1/2 T cells was seen during the culture.
antibodies at 1 mg/ml in H2O overnight at 378C), or 2.5 mg/ml ofAfter 18 hr, the cells were stained for surface TCRb and intracellular
ConA (Sigma Chemical Co.). For the mixed lymphocyte reaction,Bcl-2.
spleen cells from AKR/J (H-2k) mice were treated with g-irradiation
(4000 rad) and were used as stimulating cells. Stimulating cells
Cell Sorting and Flow Cytometric Analysis (105 cells) were incubated for 4 days with enriched splenic T cells
Freshly isolated thymocytes were stained for multicolor flow cyto- (containing 5 3 104 T cells). Cultures were pulsed with 1 mCi of
metric analysis and analyzed using a highly modified dual (488-nm [3H]thymidine for 12 hr before harvesting.
argon laser and 599-nm dye laser) or triple laser (plus 390-nm argon
laser) FACS (Becton Dickinson Immunocytometry Systems, Moun-
Acknowledgmentstain View, California) with four-decade logarithmic amplifiers. For
sorting, we subjected the sorted cells to a second round of FACS
Correspondence should be addressed to K. A. (Akashi@Darwin.sorting, and the highly purified DP (both DPint and DPhi) populations
Stanford.edu). We are indebted to Dr. S. Nishikawa for A7R34, Drs.were used for experiments. Dead cells were identified by their pro-
M. Grusby and L. H. Glimcher for MHC2/2 mice, and Dr. S. Cory forpidium iodide staining profile and excluded from analysis. Fluores-
Em-bcl-2 transgenic mice. The DNAX Research Institute of Molecularcence data were analyzed by FACS/DESK program and presented
and Cellular Biology is supported by Schering-Plough Corporation.either in the form of histograms or two-parameter probability plots
This work was mainly supported by National Cancer Institute grant(5%).
CA42551 to I. L. W., and in part by a grant from Uehara Memorial
Foundation to K. A.
Intrathymic Injection
The details of the surgical procedure have been described else-
Received February 25, 1997; revised May 12, 1997.where (Guidos et al., 1990). Thymocytes from MHC2/2 mice (Ly5.2)
were sorted into 10 ml of saline and injected into a thymic lobe of
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